The Nanobody library was created by immunizing the llama with four prostate cancer cell lines (LNCaP, VCaP, MDAPCa-2b, and PC346C), and specific nanobody (JVZ-007) was selected via bio-panning against PSMA antigen. Here, FOLH1 is linked to prostate cancer.